These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 1306148

  • 1. Anti-Jo-1 antibody in patients with polymyositis/dermatomyositis.
    Leu CC, Lan JL.
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Feb; 25(1):41-7. PubMed ID: 1306148
    [Abstract] [Full Text] [Related]

  • 2. Antibody to Jo-1 in polymyositis/dermatomyositis: association with interstitial pulmonary disease.
    Hochberg MC, Feldman D, Stevens MB, Arnett FC, Reichlin M.
    J Rheumatol; 1984 Oct; 11(5):663-5. PubMed ID: 6334746
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [The clinical significance of myositis-specific antibodies in polymyositis/dermatomyositis associated interstitial lung diseases].
    Xie MM, Yan X, Li H, Ding JJ, Gui XH, Liu Y, Wang YS, Chen ZY, Cai HR.
    Zhonghua Jie He He Hu Xi Za Zhi; 2018 Aug 12; 41(8):616-621. PubMed ID: 30138971
    [Abstract] [Full Text] [Related]

  • 5. [Clinical value of myositis antibodies in patients with connective tissue disease-associated interstitial lung diseases].
    Xie MM, Zou RY, Li Y, Liu Y, Chen LL, Liu XQ, Zhao Q, Ding JJ, Chen ZY, Cai HR.
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Oct 12; 42(10):765-770. PubMed ID: 31594111
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Anti-Jo-1 antibodies in polymyositis or dermatomyositis: evaluation by ELISA using recombinant fusion protein Jo-1 as antigen.
    Nishikai M, Ohya K, Kosaka M, Akiya K, Tojo T.
    Br J Rheumatol; 1998 Apr 12; 37(4):357-61. PubMed ID: 9619882
    [Abstract] [Full Text] [Related]

  • 10. Clinical significance of myositis-specific autoantibody profiles in Japanese patients with polymyositis/dermatomyositis.
    Temmoku J, Sato S, Fujita Y, Asano T, Suzuki E, Kanno T, Furuya MY, Matsuoka N, Kobayashi H, Watanabe H, Koga T, Shimizu T, Kawakami A, Migita K.
    Medicine (Baltimore); 2019 May 12; 98(20):e15578. PubMed ID: 31096460
    [Abstract] [Full Text] [Related]

  • 11. Clinical implications of autoantibody screening in patients with autoimmune myositis.
    Ghirardello A, Zampieri S, Tarricone E, Iaccarino L, Bendo R, Briani C, Rondinone R, Sarzi-Puttini P, Todesco S, Doria A.
    Autoimmunity; 2006 May 12; 39(3):217-21. PubMed ID: 16769655
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease.
    Gono T, Kaneko H, Kawaguchi Y, Hanaoka M, Kataoka S, Kuwana M, Takagi K, Ichida H, Katsumata Y, Ota Y, Kawasumi H, Yamanaka H.
    Rheumatology (Oxford); 2014 Dec 12; 53(12):2196-203. PubMed ID: 24970922
    [Abstract] [Full Text] [Related]

  • 14. Interstitial alveolitis as early manifestation of anti-Jo-1 positive polymyositis.
    Löhr HF, Böcher WO, Hermann E, Müller-Quernheim J, Schwickert H, Meyer zum Büschenfelde KH, Gerken G.
    Z Rheumatol; 1993 Dec 12; 52(5):307-11. PubMed ID: 8259723
    [Abstract] [Full Text] [Related]

  • 15. Interstitial lung disease outcomes by high-resolution computed tomography (HRCT) in Anti-Jo1 antibody-positive polymyositis patients: a single centre study and review of the literature.
    Ingegnoli F, Lubatti C, Ingegnoli A, Boracchi P, Zeni S, Meroni PL.
    Autoimmun Rev; 2012 Mar 12; 11(5):335-40. PubMed ID: 21985773
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clinical Characteristics and Risk Factors of Polymyositis and Dermatomyositis Combined with Interstitial Lung Disease in Patients Residing in the Northeast Sichuan Province of China.
    Li T, Tang ZY, Zhang QB, Xiao FN, Jian GL, Xie Y, Guo JW, Qing YF.
    Curr Rheumatol Rev; 2023 Mar 12; 19(4):455-462. PubMed ID: 37005523
    [Abstract] [Full Text] [Related]

  • 19. Anti-Jo-1 antibody positive polymyositis--successful therapy with leflunomide.
    Lange U, Piegsa M, Müller-Ladner U, Strunk J.
    Autoimmunity; 2006 May 12; 39(3):261-4. PubMed ID: 16769661
    [Abstract] [Full Text] [Related]

  • 20. Long-term outcome of patients with polymyositis/ dermatomyositis and anti-PM-Scl antibody.
    Marie I, Lahaxe L, Benveniste O, Delavigne K, Adoue D, Mouthon L, Hachulla E, Constans J, Tiev K, Diot E, Levesque H, Boyer O, Jouen F.
    Br J Dermatol; 2010 Feb 01; 162(2):337-44. PubMed ID: 19845665
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.